Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT04027361 · COMPLETED
Trial details
- NCT number
- NCT04027361
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-10-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.